Tobacco Regulation Report

The latest national tobacco rules and news—and what may be on the horizon
Tobacco Regulation Report

Chapter 12: Predicting the FDA’s Next Moves on E-Cigarettes

Retailers concerned over the future of electronic cigarettes may feel apprehensive about guessing where the U.S. Food and Drug Administration (FDA) will land next.The FDA’s most recent move came...

Tobacco Regulation Report

Chapter 11: New Scrutiny Over Flavors in E-Cigarettes

The U.S. Food and Drug Administration (FDA) has doubled down—some may say tripled down—on electronic cigarettes and, more specifically, flavored e-cigs.In a sweeping move to reinforce its ...

In addition to the 1,300 letters and fines issued in September, the FDA sent 12 warning letters this past spring to online retailers selling what the agency called misleadingly labeled or advertised e...

Other industry voices have chimed in on the discussion. “We are not at all surprised by the FDA’s announcement as it has been focused on this topic for quite some time and has specifically...

On Sept. 12, the FDA issued 1,300 warning letters and fines to more than 1,000 retailers as a result of a summerlong undercover operation at the store level. The list included several branded chains s...

In addition to the actions this month, the FDA is also investigating whether manufacturers introduced certain e-cigarette products to the market after Aug. 8, 2016, and may be subject to enforcement f...

Several of the e-cigarette companies issued responses to the FDA’s latest actions by press time:Altria responded with this statement: “We welcome the FDA’s action and look forward to...

The majority of the violations described in the warning letters were for the illegal sale of five e-cigarette products: Vuse, Blu, Juul, MarkTen XL and Logic, the agency said. These five brands curren...

Retailers contacted by CSP about the recent FDA actions responded with little surprise. “I believe this is one of many new initiatives from the FDA with the goal of helping create a healthier po...

The FDA wants to explore opportunities for premarket review efficiencies in the hopes it can “modernize and improve the review process.” The FDA hopes to inject an increased flexibility an...

  • Page 2